News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,714 Results
Type
Article (39085)
Company Profile (279)
Press Release (646350)
Section
Business (203882)
Career Advice (1993)
Deals (35367)
Drug Delivery (85)
Drug Development (80818)
Employer Resources (168)
FDA (16089)
Job Trends (14808)
News (344583)
Policy (32442)
Tag
Academia (2530)
Alliances (49092)
Alzheimer's disease (1229)
Approvals (16021)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11538)
Biotechnology (200)
Breast cancer (120)
Cancer (1088)
Cardiovascular disease (98)
Career advice (1662)
Cell therapy (234)
Clinical research (64262)
Collaboration (390)
Compensation (200)
COVID-19 (2533)
C-suite (94)
Data (1126)
Diabetes (152)
Diagnostics (6142)
Earnings (84821)
Employer resources (146)
Events (109498)
Executive appointments (310)
FDA (16628)
Funding (353)
Gene therapy (178)
GLP-1 (578)
Government (4327)
Healthcare (18670)
Infectious disease (2618)
Inflammatory bowel disease (108)
Interviews (308)
IPO (16303)
Job creations (3627)
Job search strategy (1419)
Layoffs (412)
Legal (7855)
Lung cancer (170)
Manufacturing (176)
Medical device (13175)
Medtech (13180)
Mergers & acquisitions (19145)
Metabolic disorders (402)
Neuroscience (1504)
NextGen Class of 2024 (6500)
Non-profit (4465)
Northern California (1481)
Obesity (232)
Opinion (179)
Patents (102)
People (56279)
Phase I (19960)
Phase II (28310)
Phase III (21103)
Pipeline (458)
Postmarket research (2554)
Preclinical (8496)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5891)
Regulatory (21526)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1302)
Startups (3565)
United States (13500)
Vaccines (550)
Weight loss (168)
Date
Today (3)
Last 7 days (668)
Last 30 days (3599)
Last 365 days (35663)
2024 (32757)
2023 (40078)
2022 (51180)
2021 (55723)
2020 (54088)
2019 (46543)
2018 (35023)
2017 (32116)
2016 (31493)
2015 (37558)
2014 (31320)
2013 (26345)
2012 (28571)
2011 (29264)
2010 (27328)
Location
Africa (714)
Arizona (192)
Asia (37128)
Australia (6061)
California (3331)
Canada (1295)
China (253)
Colorado (147)
Connecticut (153)
Europe (79532)
Florida (461)
Georgia (116)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2611)
Michigan (158)
Minnesota (273)
New Jersey (957)
New York (964)
North Carolina (702)
Northern California (1481)
Ohio (139)
Pennsylvania (847)
South America (1092)
Southern California (1302)
Texas (465)
Utah (90)
Washington State (362)
685,714 Results for "92bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Leveragen and 92Bio Forge Strategic Alliance to Advance Therapeutics Using Novel Single Domain Antibody Platform
Leveragen, Inc. announced today that it has entered into a multi-target commercial license agreement with 92Bio, Inc., a biotech firm focused on the development of therapeutic antibodies.
May 28, 2024
·
3 min read
Genetown
Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders
Triveni Bio Inc. announced a $92 million series A financing co-led by Atlas Venture and Cormorant Asset Management, with participation from OrbiMed, the private equity business of Viking Global Investors, Invus, Polaris Partners, Alexandria Venture Investments, and other investors.
October 26, 2023
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
Press Releases
TearSolutions, Inc. Secures $3M Series B Funding
November 22, 2024
·
1 min read
Press Releases
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
November 21, 2024
·
4 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
Progyny, Inc. to Present at Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
November 14, 2024
·
3 min read
1 of 68,572
Next
